Zimmermann S - Search Results

1

Scientific Advances in Lung Cancer 2015.

Tsao AS, Scagliotti GV, Bunn PA Jr, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ignatius Ou SH, Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW, Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass HI. Tsao AS, et al. Among authors: zimmermann s. J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22. J Thorac Oncol. 2016. PMID: 27013409 Free article. Review.

2

Present standards and future perspectives in the treatment of metastatic non-small cell lung cancer.

Zimmermann S, Peters S. Zimmermann S, et al. Cancer Metastasis Rev. 2015 Jun;34(2):173-82. doi: 10.1007/s10555-015-9560-6. Cancer Metastasis Rev. 2015. PMID: 25976078 Review.

3

Cerebral nocardiosis mimicking multiple brain metastases in a patient with locally advanced non-small-cell lung cancer.

Voide C, Zimmermann S, Adjei AA, Betticher DC, Meuli R, Prod'hom G, Giulieri S, Peters S. Voide C, et al. Among authors: zimmermann s. J Thorac Oncol. 2014 Mar;9(3):e24-6. doi: 10.1097/JTO.0000000000000018. J Thorac Oncol. 2014. PMID: 24518096 Free article. No abstract available.

4

Targeted therapy in NSCLC driven by HER2 insertions.

Peters S, Zimmermann S. Peters S, et al. Among authors: zimmermann s. Transl Lung Cancer Res. 2014 Apr;3(2):84-8. doi: 10.3978/j.issn.2218-6751.2014.02.06. Transl Lung Cancer Res. 2014. PMID: 25806285 Free PMC article. Review.

5

Delineating the Role of PD-1/PD-L1 Blockade in Advanced SCLC.

Zimmermann S, Peters S. Zimmermann S, et al. J Thorac Oncol. 2018 Sep;13(9):1242-1244. doi: 10.1016/j.jtho.2018.05.042. J Thorac Oncol. 2018. PMID: 30166011 Free article. No abstract available.

6

Immune Checkpoint Inhibitors in the Management of Lung Cancer.

Zimmermann S, Peters S, Owinokoko T, Gadgeel SM. Zimmermann S, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:682-695. doi: 10.1200/EDBK_201319. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231367 Free article. Review.

7

Going beyond EGFR.

Zimmermann S, Peters S. Zimmermann S, et al. Ann Oncol. 2012 Sep;23 Suppl 10:x197-203. doi: 10.1093/annonc/mds319. Ann Oncol. 2012. PMID: 22987962 Free article.

8

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.

Zimmermann S, Dziadziuszko R, Peters S. Zimmermann S, et al. Cancer Treat Rev. 2014 Jul;40(6):716-22. doi: 10.1016/j.ctrv.2014.03.005. Epub 2014 Apr 8. Cancer Treat Rev. 2014. PMID: 24759599 Review.

9

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactions.

Peters S, Zimmermann S, Adjei AA. Peters S, et al. Among authors: zimmermann s. Cancer Treat Rev. 2014 Sep;40(8):917-26. doi: 10.1016/j.ctrv.2014.06.010. Epub 2014 Jul 1. Cancer Treat Rev. 2014. PMID: 25027951 Free article.

10

Practical tips and tricks with recently approved molecular targeted agents in non-small-cell lung cancer.

Zimmermann S, Peters S. Zimmermann S, et al. EJC Suppl. 2013 Sep;11(2):307-9. doi: 10.1016/j.ejcsup.2013.07.058. EJC Suppl. 2013. PMID: 26217155 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,223 results

Search Page